Dana-Farber News shared on X:
“An article in C&EN describes a new screening platform enabling researchers to search for molecular glues more efficiently and identify a first-in-kind metabolically activated degrader that hints at a new class of protein-degrading drugs – building on previous findings from Dana-Farber’s Fischer Lab and Ebert labs.”
You can also read:
Sam Witus: Endogenous Molecular Glues Reveal New Cancer Therapy Mechanism
